Photodynamic Therapy of Oral Dysplasia with Topical 5-Aminolevulinic Acid and Light-Emitting Diode Array

Lasers in Surgery and Medicine

Volumn 34, Issue 1, 2004, Pages 18-24

  Tsai, Jui Chang ^a,b   Chiang, Chun Pin ^b   Chen, Hsin Ming ^b   Huang, Sheng Bang ^c   Wang, Chun Wei ^c   Lee, Ming I ^c   Hsu, Yih Chih ^c   Chen, Chin Tin ^b   Tsai, Tsuimin ^d  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^c INDUSTRIAL TECHNOLOGY RESEARCH INSTITUTE   (Taiwan)

^d TAIPEI MEDICAL UNIVERSITY   (Taiwan)

Author keywords

5 aminolevulinic acid; Light emitting diode; Oral leukoplakia; Photodynamic therapy

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; AMINOLEVULINIC ACID; CARBOMER; CARBOPOL 971P; DIMETHYLBENZ[A]ANTHRACENE; POLOXAMER;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BETEL NUT; CASE REPORT; CHEEK POUCH; CONTROLLED STUDY; COST BENEFIT ANALYSIS; CYTOTOXICITY; FEMALE; HAMSTER; HUMAN; HUMAN CELL; LEUKOPLAKIA; LIGHT; LIGHT EMITTING DIODE; MALE; NONHUMAN; PHOTODYNAMIC THERAPY; PHOTOSENSITIVITY DISORDER; PRECANCER; PRIORITY JOURNAL; RELIABILITY; RISK FACTOR; SQUAMOUS CELL CARCINOMA; TAIWAN;

ADMINISTRATION, TOPICAL; ADULT; AMINOLEVULINIC ACID; ANIMALS; CRICETINAE; EQUIPMENT DESIGN; FEMALE; HUMANS; LEUKOPLAKIA, ORAL; MOUTH NEOPLASMS; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS; PHOTOTHERAPY; TUMOR CELLS, CULTURED;

EID: 0345871404     PISSN: 01968092     EISSN: None     Source Type: Journal    
DOI: 10.1002/lsm.10250     Document Type: Article

References (33)

1. Cancer registry annual report in Taiwan area. Department of Health, The Executive Yuan, Taiwan, 2001.
2. Ho PS, Ko YC, Yang YH, Shieh TY, Tsai CC. The incidence of oropharyngeal cancer in Taiwan: An endemic betel quid chewing area. J Oral Pathol Med 2002;31:213-219.
3. Ko YC, Huang YL, Lee CH, Chen MJ, Lin LM, Tsai CC. Betel quid chewing, cigarette smoking and alcohol consumption related to oral cancer in Taiwan. J Oral Pathol Med 1995;24:450-453.
4. Kwan HW. A statistical study on oral carcinomas in Taiwan with emphasis on the relationship with betel nut chewing: A preliminary report. Taiwan I Hsueh Hui Tsa Chih 1976;75:497-505.
5. Chen YK, Huang HC, Lin LM, Lin CC. Primary oral squamous cell carcinoma: An analysis of 703 cases in southern Taiwan. Oral Oncol 1999;35:173-179.
6. Silverman S Jr, Gorsky M, Lozada F. Oral leukoplakia and malignant transformation. A follow-up study of 257 patients. Cancer 1984;53:563-568.
7. Lee CH, Ko YC, Huang HL, Chao YY, Tsai CC, Shieh TY, Lin LM. The precancer risk of betel quid chewing, tobacco use and alcohol consumption in oral leukoplakia and oral submucous fibrosis in southern Taiwan. Br J Cancer 2003;88:366-372.
8. Lippman SM, Benner SE, Hong WK. Cancer chemoprevention. J Clin Oncol 1994;12:851-873.
9. Henderson BW, Dougherty TJ. How does photodynamic therapy work? Photochem Photobiol 1992;55:145-157.
10. Dolmans DE, Fukumura D, Jain RK. Photodynamic therapy for cancer. Nat Rev Cancer 2003;3:380-387.
11. Weishaupt KR, Gomer CJ, Dougherty TJ. Identification of singlet oxygen as the cytotoxic agent in photoinactivation of a murine tumor. Cancer Res 1976;36:2326-2329.
12. Foote CS. Definition of type I and type II photosensitized oxidation. Photochem Photobiol 1991;54:659.
13. Dougherty TJ, Gomer CJ, Henderson BW, Jori G, Kessel D, Korbelik M, Moan J, Peng Q. Photodynamic therapy. J Natl Cancer Inst 1998;90:889-905.
14. Peng Q, Berg K, Moan J, Kongshaug M, Nesland JM. 5-Aminolevulinic acid-based photodynamic therapy: Principles and experimental research. Photochem Photobiol 1997;65:235-251.
15. Gardner LC, Smith SJ, Cox TM. Biosynthesis of delta-aminolevulinic acid and the regulation of heme formation by immature erythroid cells in man. J Biol Chem 1991;266:22010-22018.
16. Kennedy JC, Pottier RH. Endogenous protoporphyrin IX, a clinically useful photosensitizer for photodynamic therapy. J Photochem Photobiol B 1992;14:275-292.
17. Messmann H, Mlkvy P, Buonaccorsi G, Davies CL, MacRobert AJ, Bown SG. Enhancement of photodynamic therapy with 5-aminolaevulinic acid-induced porphyrin photosensitisation in normal rat colon by threshold and light fractionation studies. Br J Cancer 1995;72:589-594.
18. Friesen SA, Hjortland GO, Madsen SJ, Hirschberg H, Engebraten O, Nesland JM, Peng Q. 5-Aminolevulinic acid-based photodynamic detection and therapy of brain tumors. Int J Oncol 2002;21:577-582.
19. Soler AM, Angell-Petersen E, Warloe T, Tausjo J, Steen HB, Moan J, Giercksky KE. Photodynamic therapy of superficial basal cell carcinoma with 5-aminolevulinic acid with dimethylsulfoxide and ethylendiaminetetraacetic acid: A comparison of two light sources. Photochem Photobiol 2000;71:724-729.
20. Mlkvy P, Messmann H, Regula J, Conio M, Pauer M, Millson CE, MacRobert AJ, Bown SG. Photodynamic therapy for gastrointestinal tumors using three photosensitizers-ALA induced PPIX, photofrin and mTHPC. A pilot study. Neoplasma 1998;45:157-161.
21. Kennedy JC, Marcus SL, Pottier RH. Photodynamic therapy (PDT) and photodiagnosis (PD) using endogenous photosensitization induced by 5-aminolevulinic acid (ALA): Mechanisms and clinical results. J Clin Laser Med Surg 1996;14:289-304.
22. Nauta JM, van Leengoed HL, Star WM, Roodenburg JL, Witjes MJ, Vermey A. Photodynamic therapy of oral cancer. A review of basic mechanisms and clinical applications. Eur J Oral Sci 1996;104:69-81.
23. Fan KF, Hopper C, Speight PM, Buonaccorsi G, MacRobert AJ, Bown SG. Photodynamic therapy using 5-aminolevulinic acid for premalignant and malignant lesions of the oral cavity. Cancer 1996;78:1374-1383.
24. Biel MA. Photodynamic therapy and the treatment of head and neck neoplasia. Laryngoscope 1998;108:1259-1268.
25. Mosmann T. Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays. J Immunol Methods 1983;65:55-63.
26. Schmolka JR. Artificial skin. I. Preparation and properties of pluronic F-127 gels for treatment of burns. J Biomed Mater Res 1972;6:571-582.
27. Chen C-T, Chiang HHK, Chow S-N, Wang C-Y, Lee Y-S, Tsai J-C, Chiang C-P. Autofluoreseence in normal and malignant human oral tissues and in DMBA-induced hamster buccal pouch carcinogenesis. J Oral Pathol Med 1998;27:470-474.
28. Hopper C. Photodynamic therapy: A clinical reality in the treatment of cancer. Lancet Oncology 2000;1:212-219.
29. Moan JK, Berg XX, Iani V. Action spectra of dyes relevant for photodynamic therapy. In: Moser JG, editor. Photodynamic Tumor Therapy. Amsterdam: Harwood Academic Publishers; 1998:169-181.
30. Stringer MR. Problems associated with the use of broad-band illumination sources for photodynamic therapy. Phys Med Biol 1995;40:1733-1735.
31. Gerscher S, Connelly JP, Griffiths J, Brown SB, MacRobert AJ, Wong G, Rhodes LE. Comparison of the pharmacokinetics and phototoxicity of protoporphyrin IX metabolized from 5-aminolevulinic acid and two derivatives in human skin in vivo. Photochem Photobiol 2000;72:569-574.
32. Kubler A, Haase T, Rheinwald M, Barth T, Muhling J. Treatment of oral leukoplakia by topical application of 5-aminolevulinic acid. Int J Oral Maxillofac Surg 1998;27:466-469.
33. Rhodes LE, Tsoukas MM, Anderson RR, Kollias N. Iontophoretic delivery of ALA provides a quantitative model for ALA pharmacokinetics and PpIX phototoxicity in human skin. J Invest Dermatol 1997;108:87-91.